Zhengye Biotechnology Holding (ZYBT) Short term Debt (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Short term Debt for 3 consecutive years, with $98694.8 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Short term Debt fell 90.14% year-over-year to $98694.8 in Q4 2025; TTM through Dec 2025 was $98694.8, a 90.14% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, down 89.85% from the prior year.
• Short term Debt was $98694.8 for Q4 2025 at Zhengye Biotechnology Holding, up from $28000.0 in the prior quarter.
• Over five years, Short term Debt peaked at $11.1 million in Q4 2023 and troughed at $28000.0 in Q2 2025.
• A 3-year average of $3.1 million and a median of $549827.9 in 2024 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt plunged 90.98% in 2024 and plunged 90.14% in 2025, its largest moves.
• Over 3 years, Short term Debt stood at $11.1 million in 2023, then sank by 90.98% to $1.0 million in 2024, then sank by 90.14% to $98694.8 in 2025.
• The last three Short term Debt figures came in at $98694.8 (Q4 2025), $28000.0 (Q2 2025), and $1.0 million (Q4 2024), per Business Quant data.